Bio Green Med Solution

Bio Green Med Solution Enterprise Value

The Enterprise Value (EV) of Bio Green Med Solution (BGMS) as of Nov 17, 2026 is 1.01 M USD. In the previous year, Enterprise Value (EV) was 1.37 M USD — a change of -26.69% (lower).

Enterprise Value

1.01 MUSD

YoY

-26.69%

Last updated:

Enterprise Value (EV) of Bio Green Med Solution is 2025 1.01 M USD. Enterprise Value (EV) of Bio Green Med Solution was 2024 1.37 M USD. It decreases by -26.69% lower compared to the previous year.

The Bio Green Med Solution Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
-13.00 M USD
Jan 1, 2019
-6.19 M USD
Jan 1, 2020
-27.84 M USD
Jan 1, 2021
-32.02 M USD
Jan 1, 2022
-13.73 M USD
Jan 1, 2023
1.17 M USD
Jan 1, 2024
1.37 M USD
Jan 1, 2025
1.01 M USD
The Bio Green Med Solution Enterprise Value history
YEAREnterprise ValueYoY
1.01 MUSD-26.69%
1.37 MUSD+17.48%
1.17 MUSD-108.50%
-13.73 MUSD-57.12%
-32.02 MUSD+15.01%
-27.84 MUSD+350.07%
-6.19 MUSD-52.40%
-13.00 MUSD-33.47%
-19.53 MUSD+60.85%
-12.14 MUSD-24.40%
-16.06 MUSD-18.92%
-19.81 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Green Med Solution Stock analysis

What does Bio Green Med Solution do? Cyclacel Pharmaceuticals, Inc. generates revenue through its clinical stage biopharmaceutical products, focusing on anticancer drugs that target the cell cycle. The company's product portfolio includes sapacitabine, a nucleoside analog for oral administration, seliciclib as a CDK inhibitor, and CYC065, a second-generation CDK inhibitor. These drugs are developed for hematological malignancies and solid tumors, with sapacitabine and seliciclib being key candidates in their pipeline. The company sells its products to healthcare providers and pharmaceutical distributors in the oncology sector. The firm's lead candidate, sapacitabine, is positioned as an alternative to conventional chemotherapies like gemcitabine and cytarabine (Ara-C), which are generic drugs already in use. Seliciclib, an oral CDK2/9 inhibitor, and CYC065, targeting CDK2/9 enzymes, are marketed for their utility in treating various cancers. The company's revenue streams are derived from clinical development partnerships and potential future commercialization of these drugs once approved. Cyclacel's business model centers on developing and advancing its drug candidates through clinical trials, with the goal of securing regulatory approvals and partnering with larger pharmaceutical companies for distribution. The company does not yet have commercial products on the market, so its current revenue comes from research grants and potential licensing agreements. The primary customer segments are oncology specialists and pharmaceutical distributors specializing in cancer treatments. Bio Green Med Solution is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Green Med Solution stock

Enterprise Value (EV) of Bio Green Med Solution is 1.01 M USD in 2025.

Enterprise Value (EV) of Bio Green Med Solution changed from 1.37 M USD to 1.01 M USD, representing a -26.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Bio Green Med Solution since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Bio Green Med Solution with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Bio Green Med Solution

All Key Metrics — Bio Green Med Solution